Hepatitis C virus (HCV) is a leading cause of chronic liver disease and mortality worldwide. The World Health Assembly and WHO have recognised the need to prevent and control HCV infection, and WHO proposed that elimination was feasible by 2030 by reducing new chronic infections by 90% and HCV-related mortality by 65%. In the USA, as many as 3 million people are chronically infected with HCV, with more than 30 000 new infections occurring every year.¹ Elimination strategies are urgently needed that focus on the estimated 1·3 million people who inject drugs in the USA, the group at highest risk for acquiring and transmitting HCV infection.

中文翻译：

---

如何在美国注射毒品的人中消除HCV。

丙型肝炎病毒（HCV）是全球慢性肝病和死亡的主要原因。世界卫生大会和世界卫生组织已经认识到预防和控制HCV感染的必要性，WHO提出到2030年消除是可行的，方法是将新的慢性感染减少90％，并将与HCV相关的死亡率降低65％。在美国，每年有多达300万人被HCV慢性感染，每年有3万多新发感染。¹迫切需要一种消除策略，该策略应集中在美国大约1300万注射毒品的人群上，该人群是获得和传播HCV感染风险最高的人群。